IP Library › Granted Patent US 11,079,374
Granted Patent B2
US 11,079,374 · App. 16/495,833 · Granted Aug 3, 2021

Methods and kits for exosome isolation and quantification

Inventors: Dapi Meng Lin Chiang (Taipei, TW); Michael W. Pfaffl (Freising, DE); Dominik Buschmann (Freising, DE)
Assignees: Dapi Meng Lin Chiang; Michael W. Pfaffi; BIOVESICLE INC
G01N33/54326G01N15/1404G01N33/5306G01N2333/42G01N2333/4724
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,079,374
App. No.
16/495,833
Granted
Aug 3, 2021
Kind
B2
Abstract

Disclosed herein are methods and kits for isolating exosomes in a sample. The method comprises contacting and incubating a plurality of galectin-3-modified magnetic beads with the sample, followed by subjecting the mixture to a magnetic field and then isolating the exosomes from the magnetic beads by a lactose solution. The kit of the present disclosure comprises a plurality galectin-3-modified magnetic beads, a lactose solution having a pH value of 6.8 to 7.6, and an exosome-free buffer.

Claims (15)

1. A method for isolating exosomes in a sample, comprising the steps of,

(a) contacting a plurality of lectin-modified magnetic beads with the sample to obtain a first mixture, wherein the plurality of lectin-modified magnetic beads are suspended in an exosome-free buffer, and each lectin-modified magnetic bead comprises a plurality of lectin molecules that are covalently bonded to the magnetic bead, wherein the exosome-free buffer is an exosome-free bovine serum albumin or exosome-free human serum albumin, and the lectin is galectin-3;

(b) incubating the first mixture at a condition allowing the exosomes to conjugate with the lectin molecules of the lectin-modified magnetic beads thereby obtaining a second mixture comprising a plurality of exosome-bead complexes;

(c) subjecting the second mixture from the step (b) to a magnetic field, thereby separating the exosome-bead complexes from the remainder of the second mixture; and

(d) separating the exosomes from the magnetic beads by eluting the exosome-bead complexes from the step (c) using an elution buffer having a pH value of 6.8 to 7.6, wherein the elution buffer is a lactose solution consisting essentially of lactose.

2. The method according to the claim 1 , wherein the lactose solution is 1-10% (wt %) lactose solution.

3. The method according to claim 1 , wherein the sample is an uncultured biological sample obtained from a subject.

4. The method according to the claim 3 , wherein the uncultured biological sample is derived from peripheral blood, serum, plasma, ascites, urine, cerebrospinal fluid (CSF), sputum, saliva, bone marrow, synovial fluid, aqueous humor, amniotic fluid, cerumen, breast milk, broncheoalveolar lavage fluid, semen, prostatic fluid, pre-ejaculatory fluid, female ejaculate, sweat, fecal matter, tears, cyst fluid, pleural and peritoneal fluid, pericardial fluid, lymph, chyme, chyle, bile, interstitial fluid, menses, pus, sebum, vomit, vaginal secretions, mucosal secretion, stool water, pancreatic juice, lavage fluids from sinus cavities, bronchopulmonary aspirates, blastocyl cavity fluid, or umbilical cord blood of the subject.

5. The method according to claims 3 , wherein the subject is a human.

6. The method according to claim 1 , wherein the sample is a cultured sample.

7. A kit for isolating and exosomes in a sample, comprising, a plurality of lectin-modified magnetic beads, an elution buffer having a pH value of 6.8 to 7.6, and an exosome-free buffer, wherein

each lectin-modified magnetic bead comprises a plurality of lectin molecules that are covalently bonded to the magnetic bead, wherein the lectin is galectin-3;

the elution buffer is a lactose solution consisting essentially of lactose; and

the exosome-free buffer is an exosome-free bovine serum albumin or exosome-free human serum albumin.

8. The kit according to the claim 7 , wherein the lactose solution is 1-10% (wt %) lactose solution.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2019
From: CHIANG, DAPI MENG LIN; PFAFFL, MICHAEL W.; BUSCHMANN, DOMINIK
To: CHIANG, DAPI MENG LIN; PFAFFL, MICHAEL W.; BIOVESICLE INC
Reel/Frame 051057/0175 →
Continuity (1)
Related Publication 20200132682A1 · Apr 30, 2020